Prismlab Receives Funding from BASF Venture Capital and SABIC Venture Capital
Prismlab, a leading provider of 3D printing processes and 3D printers, headquartered in Shanghai, has secured strategic investment from BASF Venture Capital GmbH alongside co-investor Sabic Ventures.
The official signing ceremony was held in Shanghai on 3rd November 2018 with all parties in attendance. This is BASF Venture Capital GmbH’s first direct investment in a Chinese company. Prismlab has developed a patented printing process that is characterized by a very high printing speed, high level of precision and lower printing costs. BASF’s venture investment will enable Prismlab to further accelerate its product development and innovation while strengthening its market reach to the global market.
“This is our first direct investment in a Chinese company,” said Markus Solibieda, Managing Director of BASF Venture Capital GmbH. “The trailblazing technology from Prismlab allows large and stable components, such as medical braces and anatomical models, to be 3D printed for the first time. This investment supports BASF’s strategy of actively advancing our technologies and expanding our product offering in the 3D printing sector.”
“China is transforming from a manufacturing-driven to an innovation-driven economy. This investment in Prismlab reflects our commitment to further expanding our innovation capabilities in China, and BASF Venture Capital plays an important role in helping us identifying potential partners that lead us to success,” said Dr. Zheng Daqing, BASF’s Senior Vice President, Business and Market Development Greater China.
“The 3D printing technology must continue to evolve before it is set to change the world. At Prismlab, we aim to spearhead and accelerate that change by providing solutions through specialized customization. The investment allows us to stay laser-focused on our R&D capability, a key factor to achieve that goal,” said Mr. Hou Feng, Founder and Chairman of Prismlab